Coherent Biopharma Overview

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

Coherent Biopharma General Information

Description

Developer of biopharmaceutical drugs designed to advance targeted therapies for cancer and other serious diseases. The company offers bi-targeting drug conjugate technology, proprietary ligand discovery platforms and targeted payload delivery mechanisms, enabling healthcare researchers and oncology patients to access precision therapeutics with improved cellular targeting and therapeutic efficacy

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 2-3, C36, Biopharmaceutical Industrial Park
  • Number 218, Xinghu Street
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • Level 2-3, C36, Biopharmaceutical Industrial Park
  • Number 218, Xinghu Street
  • Suzhou, Jiangsu 215123
  • China
+86 0512

Coherent Biopharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coherent Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Mar-2026 Completed Clinical Trials - Phase 2
7. Secondary Transaction - Private 31-Aug-2023 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series B1) 12-May-2023 Completed Clinical Trials - Phase 2
5. Secondary Transaction - Private 21-Dec-2022 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 01-Aug-2022 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series A1) 15-Nov-2018 Completed Clinical Trials - Phase 1
2. Early Stage VC 22-Mar-2017 $30M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 15-Feb-2016 $30M $30M Completed Clinical Trials - Phase 1
To view Coherent Biopharma’s complete valuation and funding history, request access »

Coherent Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical drugs designed to advance targeted therapies for cancer and other serious diseases. The c
Drug Discovery
Suzhou, China
100 As of 2023

Beijing, China
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Coherent Biopharma Competitors (37)

One of Coherent Biopharma’s 37 competitors is Mabworks Biotech, a Venture Capital-Backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mabworks Biotech Venture Capital-Backed Beijing, China
Macrogenics Formerly VC-backed Rockville, MD
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
CureGenetics Venture Capital-Backed Suzhou, China
BoomRay Pharmaceuticals Venture Capital-Backed Suzhou, China
You’re viewing 5 of 37 competitors. Get the full list »

Coherent Biopharma Patents

Coherent Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025092703-A1 Photosensitizer conjugate compound, pharmaceutical composition thereof, and use thereof Inactive 30-Oct-2023
WO-2024222803-A1 Use of ligand-drug conjugate in treatment of cancer Inactive 26-Apr-2023
WO-2024193675-A1 Treatment of ovarian cancer by administration of ligand-drug conjugate Inactive 23-Mar-2023
WO-2024131944-A1 Pharmaceutical composition, and preparation method therefor and use thereof Inactive 23-Dec-2022
WO-2024120523-A1 Pharmaceutical composition for treating prostate cancer and use thereof Inactive 09-Dec-2022 A61K38/07
To view Coherent Biopharma’s complete patent history, request access »

Coherent Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coherent Biopharma Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
HM Venture Partners Venture Capital Minority
120 Capital Venture Capital Minority
Hefei Hi-Tech VC Venture Capital Minority
Hefei Industry Investment Group Venture Capital Minority
Shanghai Alliance Investment Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Coherent Biopharma FAQs

  • Where is Coherent Biopharma headquartered?

    Coherent Biopharma is headquartered in Suzhou, China.

  • What is the size of Coherent Biopharma?

    Coherent Biopharma has 100 total employees.

  • What industry is Coherent Biopharma in?

    Coherent Biopharma’s primary industry is Drug Discovery.

  • Is Coherent Biopharma a private or public company?

    Coherent Biopharma is a Private company.

  • What is Coherent Biopharma’s current revenue?

    The current revenue for Coherent Biopharma is .

  • How much funding has Coherent Biopharma raised over time?

    Coherent Biopharma has raised $130M.

  • Who are Coherent Biopharma’s investors?

    HM Venture Partners, 120 Capital, Hefei Hi-Tech VC, Hefei Industry Investment Group, and Shanghai Alliance Investment are 5 of 10 investors who have invested in Coherent Biopharma.

  • Who are Coherent Biopharma’s competitors?

    Mabworks Biotech, Macrogenics, CytomX Therapeutics, CureGenetics, and BoomRay Pharmaceuticals are some of the 37 competitors of Coherent Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process